Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
18.81
+1.34 (7.67%)
At close: Jul 20, 2026, 4:00 PM EDT
19.18
+0.37 (1.97%)
After-hours: Jul 20, 2026, 7:53 PM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $1.39 billion as of July 20, 2026. Its market cap has increased by 118.45% in one year.
Market Cap
1.39B
Enterprise Value
967.42M
1-Year Change
118.45%
Ranking
Category
Stock Price
$18.81
ChartMarket Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.39B, an increase of 468.30%. That is a compound annual growth rate of 14.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.39B | 27.56% |
| Dec 31, 2025 | 1.09B | -32.02% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.38B |
| Novavax | 1.35B |
| Immatics | 1.31B |
| Ardelyx | 1.28B |
| Inhibrx Biosciences | 1.28B |
| First Tracks Biotherapeutics | 1.27B |
| Avalyn Pharma | 1.25B |
| Corvus Pharmaceuticals | 1.25B |